PRGO
46
3
AMZN
56
3
SPG
50
2
APH
58
3
SWKS
46
-2
CINF
61
-5
BRK.B
42
2
EIX
56
-3
ORLY
43
2
O
31
-2
DRI
60
-3
BEN
55
-2
MPC
39
3
ICE
62
2
ADP
53
-2
PVH
28
-2
AA
80
-3
AMT
26
2
DVA
47
-4
FE
52
2
PRGO
46
3
AMZN
56
3
SPG
50
2
APH
58
3
SWKS
46
-2
CINF
61
-5
BRK.B
42
2
EIX
56
-3
ORLY
43
2
O
31
-2
DRI
60
-3
BEN
55
-2
MPC
39
3
ICE
62
2
ADP
53
-2
PVH
28
-2
AA
80
-3
AMT
26
2
DVA
47
-4
FE
52
2
Financhill
Back

Biogen, Inc. Vs. Nektar Therapeutics Industry Stock Comparison

Sell
50

BIIB
Biogen, Inc.

Last Price:
$176.48
Seasonality Move:
8.72%
Sell
45

NKTR
Nektar Therapeutics

Last Price:
$43.88
Seasonality Move:
6.44%
Sell
50
Biogen, Inc. (BIIB) is a Sell

Is Biogen, Inc. a Buy, Sell or Hold?

  • The current Biogen, Inc. [BIIB] share price is $174.82. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $44.46. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen, Inc.'s stock price today?

  • The Biogen, Inc. share price today is $174.82
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $44.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.05 Buy
Relative Strength Index (14 RSI): 54.84 Buy
Chaikin Money Flow: 502428 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (171.45 - 180.47) Sell
Bollinger Bands (100): (136.37 - 168.21) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.56 Sell
Relative Strength Index (14 RSI): 37.11 Sell
Chaikin Money Flow: 657085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.71 - 61.11) Sell
Bollinger Bands (100): (35.93 - 62.65) Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 173.46 Buy
20-day SMA: 177.1 Sell
50-day SMA: 164.12 Buy
200-day SMA: 140.31 Buy
8-day EMA: 174.19 Buy
20-day EMA: 173.65 Buy
50-day EMA: 166.11 Buy
200-day EMA: 152.66 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.67 Sell
20-day SMA: 54.26 Sell
50-day SMA: 56.89 Sell
200-day SMA: 31.84 Buy
8-day EMA: 47.39 Sell
20-day EMA: 51.76 Sell
50-day EMA: 53.5 Sell
200-day EMA: 38.45 Buy

Biogen, Inc. Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.17 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

Biogen, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):